China SXT Pharmaceuticals, Inc. (SXTC) |
| 0.0774 -0.025 (-24.12%) 10-13 16:00 |
| Open: | 0.0802 |
| High: | 0.0838 |
| Low: | 0.0659 |
| Volume: | 57,254,562 |
| Market Cap: | 0(M) |
| PE Ratio: | 0.03 |
| Exchange: | NASDAQ |
| Industry: | Drug Manufacturers - Specialty & Generic |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 9.59 |
| Resistance 1: | 5.95 |
| Pivot price: | 1.88 |
| Support 1: | 0.07 |
| Support 2: | 0.05 |
| 52w High: | 83760 |
| 52w Low: | 0.0659 |
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.
| EPS | -730.400 |
| Book Value | 2.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 133709.672 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | -153.28 |
| Return on Assets (ttm) | -15.8 |
| Return on Equity (ttm) | -27.5 |
Sat, 10 Oct 2026
China SXT Pharmaceuticals, Inc. (SXTC) Stock Price, News, Quote & History - Yahoo! Finance Canada
Fri, 09 Oct 2026
China SXT Pharmaceuticals closes $12 million registered offering - Investing.com
Fri, 09 Oct 2026
A zero-price warrant option could add shares following China SXT (SXTC)'s completed offering. - Stock Titan
Fri, 09 Oct 2026
China SXT Pharmaceuticals Terminates $3 Million Offshore Share and Warrant Offering - The Globe and Mail
Thu, 08 Oct 2026
China SXT Pharmaceuticals Announces $12 Million Registered Direct Offering With Significant Dilution Potential - Yahoo Finance
Thu, 08 Oct 2026
China SXT Pharmaceuticals Inc. Announces $12 Million Registered Direct Offering - Stock Titan
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |